Cardiovascular drug trial fails, experts surprised by complete lack of efficacy

A drug previously expected to treat heart disease has failed in clinical trials, showing no benefit. The failure is unexpected and raises questions about the drug's mechanism and the trial design. This matters for patients and investors in the pharmaceutical sector, though specific drug and trial details are not provided.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works